JP2025500346A5 - - Google Patents
Info
- Publication number
- JP2025500346A5 JP2025500346A5 JP2024537380A JP2024537380A JP2025500346A5 JP 2025500346 A5 JP2025500346 A5 JP 2025500346A5 JP 2024537380 A JP2024537380 A JP 2024537380A JP 2024537380 A JP2024537380 A JP 2024537380A JP 2025500346 A5 JP2025500346 A5 JP 2025500346A5
- Authority
- JP
- Japan
- Prior art keywords
- sleep apnea
- respiratory disorders
- oxybutynin
- snoring
- combination according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21216889 | 2021-12-22 | ||
| EP21216889.2 | 2021-12-22 | ||
| PCT/EP2022/086928 WO2023118098A1 (en) | 2021-12-22 | 2022-12-20 | COMBINATION OF AN α2-ADRENOCEPTOR SUBTYPE C (ALPHA-2C) ANTAGONISTS WITH A MUSCARINIC RECEPTOR ANTAGONIST FOR THE TREATMENT OF SLEEP APNEA |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025500346A JP2025500346A (ja) | 2025-01-09 |
| JP2025500346A5 true JP2025500346A5 (https=) | 2025-12-05 |
Family
ID=79021054
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024537380A Pending JP2025500346A (ja) | 2021-12-22 | 2022-12-20 | 睡眠時無呼吸の治療のためのα２－アドレナリン受容体サブタイプＣ（アルファ－２Ｃ）アンタゴニストとムスカリン受容体アンタゴニストとの組合せ |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20250057828A1 (https=) |
| EP (1) | EP4452245A1 (https=) |
| JP (1) | JP2025500346A (https=) |
| KR (1) | KR20240127392A (https=) |
| CN (1) | CN118434414A (https=) |
| AU (1) | AU2022422053A1 (https=) |
| CA (1) | CA3259602A1 (https=) |
| IL (1) | IL313654A (https=) |
| MX (1) | MX2024007767A (https=) |
| TW (1) | TW202342011A (https=) |
| WO (1) | WO2023118098A1 (https=) |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3966781A (en) | 1970-12-17 | 1976-06-29 | Merck Sharp & Dohme (I.A.) Corporation | Deuteration of functional group-containing hydrocarbons |
| HRP20041026A2 (en) | 2002-04-03 | 2005-06-30 | Orion Corporation | Polycyclic compounds as potent alpha2-adrenoceptor antagonists |
| US8791162B2 (en) | 2011-02-14 | 2014-07-29 | Merck Sharp & Dohme Corp. | Cathepsin cysteine protease inhibitors |
| WO2017031319A1 (en) | 2015-08-18 | 2017-02-23 | Massachusetts Institute Of Technology | Noradrenergic drug treatment of obstructive sleep apnea |
| GEAP202416602A (en) | 2017-04-28 | 2024-10-10 | Brigham & Womens Hospital Inc | Methods and compositions for treating sleep apnea |
| KR102874891B1 (ko) | 2018-01-30 | 2025-10-21 | 애프니메드, 인코포레이티드 (델라웨어) | 수면 무호흡증을 치료하기 위한 방법 및 조성물 |
| US20210338662A1 (en) * | 2018-09-25 | 2021-11-04 | Bayer Aktiengeselischaft | Alpha-2-adrenoceptor subtype c (alpha-2c) antagonists for the treatment of sleep apnea |
| CA3139298A1 (en) | 2019-05-09 | 2020-11-12 | Bayer Aktiengesellschaft | Combination of an a2-adrenoceptor subtype c (alpha-2c) antagonists with a task1/3 channel blocker for the treatment of sleep apnea |
| TW202108139A (zh) | 2019-05-09 | 2021-03-01 | 德商拜耳廠股份有限公司 | 用於治療睡眠呼吸中止之α２—腎上腺素受體亞型Ｃ（α—２Ｃ）拮抗劑與ＴＡＳＫ１／３通道阻斷劑之組合 |
| EP3965763A1 (en) * | 2019-05-09 | 2022-03-16 | Bayer Aktiengesellschaft | Arylquinoziline derivatives as alpha2-adrenoceptor subtype c (alpha-2c) antagonists for the treatment of sleep apnea |
| PE20221025A1 (es) | 2019-11-06 | 2022-06-16 | Bayer Ag | Inhibidores de los receptores a2c adrenergicos |
| WO2022008426A1 (en) * | 2020-07-06 | 2022-01-13 | Bayer Aktiengesellschaft | Combination of an alpha2-adrenoceptor subtype c (alpha-2c) antagonist with a task1/3 channel blocker for the treatment of sleep apnea |
-
2022
- 2022-12-20 CA CA3259602A patent/CA3259602A1/en active Pending
- 2022-12-20 WO PCT/EP2022/086928 patent/WO2023118098A1/en not_active Ceased
- 2022-12-20 MX MX2024007767A patent/MX2024007767A/es unknown
- 2022-12-20 US US18/722,233 patent/US20250057828A1/en active Pending
- 2022-12-20 KR KR1020247024052A patent/KR20240127392A/ko active Pending
- 2022-12-20 JP JP2024537380A patent/JP2025500346A/ja active Pending
- 2022-12-20 IL IL313654A patent/IL313654A/en unknown
- 2022-12-20 TW TW111148913A patent/TW202342011A/zh unknown
- 2022-12-20 EP EP22840695.5A patent/EP4452245A1/en active Pending
- 2022-12-20 AU AU2022422053A patent/AU2022422053A1/en active Pending
- 2022-12-20 CN CN202280085160.3A patent/CN118434414A/zh active Pending